AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

DIA 2018

                         

June 24-28, 2018   |  Boston Convention & Exhibition Center (BCEC)  |  Boston, MA

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem. Sessions will include distinguished speakers and expert panelists from regulatory, industry, patient advocacy, and academia. Engage with global decision makers and influencers in the biotechnology hub of 2018 that you would not otherwise have access to. Advance health care product development globally and grow your career while doing so.

 

Join Avoca for the Following Sessions:

.

.

.

 

.

.

 

.

.

.

.

.

…….. .

TUESDAY, JUNE 26  |  8:00am – 9:00am

Oversight in the Era of E6 (R2)

Component Type: Session     Level: Intermediate

This session will outline the characteristics that define common outsourcing models and expose their corresponding risk/benefit ratio with regard to sponsor and CRO oversight. Case studies of proven solutions within each model will be presented and linked to recommendations to achieve enhanced oversight in the era of E6 (R2).

Learning Objectives: Discuss the risk/benefit ratio with regard to sponsor and CRO oversight in common outsourcing models; Identify methods to implement improved and more efficient approaches to clinical trial oversight.

 

Chair:

Melissa Bomben, MS, Vice President, Strategic Resourcing, Syneos Health

 

Panelist:

Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group

.

.

.

.

.

.

.

…….. .

 

TUESDAY, JUNE 26  |  10:30am – 11:30am

Executives Respond to the State of the Industry report on Risk Based Approaches in Clinical Trials: Opportunity or Threat?

Component Type: Forum Level: Intermediate

Part didactic presentation, part lively debate and discussion among an executive panel, dive deep into the state of risk in clinical trials and explore our data on risk assessment and risk-based approaches to clinical trial oversight and execution.

Learning Objectives: Identify the most recent information regarding the state of the industry for familiarity, use, impact and satisfaction with risk assessment and risk-based approaches in clinical research; Develop new perspectives on how to shape their individual and organizational perspectives and positioning with respect to changing regulatory requirements and evolving risk landscape.

 

Chair:

Dennis Salotti, MBA, MS, Vice President, Operations, The Avoca Group

 

Panelists:

Neil McCullough, Executive Vice President, Clinical Quality and Compliance, ICON Clinical Research
Bari Kowal, MS, Head of Global Clinical Operations, Regeneron

 

To schedule a meeting with an Avoca representative at this event, contact us.